Lantheus Holdings, Inc. current report, 26 February 2018

Abrir documento

Lantheus Holdings, Inc. - Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K was filed by Lantheus Holdings, Inc. on February 26, 2018. The filing reports on corporate governance changes, specifically the appointment of new members to the Board of Directors effective February 26, 2018.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel appointments and does not contain financial performance data.

Material Changes

The Board of Directors increased its size from nine to ten members to accommodate the appointment of three new Class III Directors:

  • Gary J. Pruden: Former Executive Vice President and Worldwide Chairman of Medical Devices at Johnson & Johnson. Appointed to the Audit Committee and the Financing and Strategy Committee.
  • Kenneth J. Pucel: Executive Vice President of Global Operations at Polaris Industries Inc. and former executive at Boston Scientific. Appointed to the Compensation Committee.
  • Dr. James H. Thrall: Professor of Radiology at Harvard Medical School and former Chairman of Radiology at Massachusetts General Hospital. Appointed to the Nominating and Corporate Governance Committee.

Each new director's initial term expires at the Company's 2018 annual meeting of stockholders.

Compensation and Governance

The new directors will receive standard non-employee director compensation, including:

  • Base Board Fee: $50,000 per calendar year (prorated for 2018).
  • Committee Fees:
    • Mr. Pruden: $10,000 (Audit Committee) and $5,000 (Financing and Strategy Committee).
    • Mr. Pucel: $7,500 (Compensation Committee).
    • Dr. Thrall: $5,000 (Nominating and Corporate Governance Committee).
  • Reimbursement for out-of-pocket expenses.

Investor Verification Checklist

  • Verify the biographical details and potential conflicts of interest for the three new directors via the attached press release (Exhibit 99.1).
  • Confirm the total number of directors on the Board is now ten.
  • Review the Company's 2018 Annual Meeting proxy statement for details on the upcoming election of these Class III Directors.
  • Note that this filing contains no financial data; refer to the most recent 10-K or 10-Q for financial metrics.